Cite
HARVARD Citation
Chen, Y. et al. (2015). A comparison of safety profiles of tumour necrosis factor α inhibitors and rituximab therapy in patients with rheumatoid arthritis and chronic hepatitis C. Annals of the rheumatic diseases. 74 (3), pp. 626-627. [Online].